# Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

> **NCT02012608** · PHASE2 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 14 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Glutamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02012608
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Lack of funding/ PI leaving institution
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012608, "Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02012608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*